Science Explorer Back to mapMap
Discussion
Institution · Compass Research

Most cited papers from Compass Research

Compass Research

What are the most cited papers from Compass Research?

The most cited paper from Compass Research is "Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density" (Craig T Curtis et al., 2015), with 344 citations. Next come "Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy" (273) and "ABBY" (254).

Showing 34 of 34 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density Craig T Curtis et al. · JAMA Neurology Open access 26 Jan 2015 344
2 Effect of High-frequency (10-kHz) Spinal Cord Stimulation in Patients With Painful Diabetic Neuropathy Erika Petersen et al. · JAMA Neurology Open access 5 Apr 2021 273
3 ABBY Jeffrey L. Cummings, Sharon Cohen, Christopher H. van Dyck et al. · Neurology Open access 25 Apr 2018 254
4 Targeting Prodromal Alzheimer Disease With Avagacestat Vladimir Coric et al. · JAMA Neurology Open access 28 Sep 2015 236
5 Performance of [18F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA‐AA recommendations for the neuropathologic diagnosis of Alzheimer's disease Stephen Salloway et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring Open access 2017 94
6 A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant Judith Falloon, Fei Ji, Craig T Curtis et al. · Vaccine Open access 22 Apr 2016 63
7 Wireless High-Frequency Spinal Cord Stimulation (10 kHz) Compared with Multiwaveform Low-Frequency Spinal Cord Stimulation in the Management of Chronic Pain in Failed Back Surgery Syndrome Subjects: Preliminary Results of a Multicenter, Prospective Randomized Controlled Study Robert Bolash, Michael J. Creamer, Richard L Rauck et al. · Pain Medicine Open access 22 Jan 2019 44
8 Dose Selection for an Adjuvanted Respiratory Syncytial Virus F Protein Vaccine for Older Adults Based on Humoral and Cellular Immune Responses Judith Falloon, H. Keipp Talbot, Craig T Curtis et al. · Clinical and Vaccine Immunology Open access 6 Jul 2017 35
9 Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72 Melissa Erin Murray, Kevin F. Bieniek, Marianne Banks Greenberg et al. · Acta Neuropathologica Open access 6 Aug 2013 35
10 Safety and pharmacodynamics of venetoclax (ABT-199) in a randomized single and multiple ascending dose study in women with systemic lupus erythematosus Peng Lü, Roy Fleischmann, C. Martin Curtis et al. · Lupus 10 Jul 2017 33
11 Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency Peter Alexander Ljubenkov et al. · JAMA Network Open Open access 24 Sep 2021 30
12 A Prospective, Randomized, Multicenter, Open-label Clinical Trial Comparing Intradiscal Biacuplasty to Conventional Medical Management for Discogenic Lumbar Back Pain Mehul J. Desai, Leonardo Kapural, Jeffrey D. Petersohn et al. · Spine 21 Dec 2015 28
13 Twelve-Month Follow-up of a Randomized Clinical Trial Comparing Intradiscal Biacuplasty to Conventional Medical Management for Discogenic Lumbar Back Pain Mehul J. Desai, Leonardo Kapural, Jeffrey D. Petersohn et al. · Pain Medicine 28 Aug 2016 25
14 A novel non-PPARgamma insulin sensitizer: MLR-1023 clinicalproof-of-concept in type 2 diabetes mellitus Moon‐Kyu Lee, Sin Gon Kim, Elaine Watkins et al. · Journal of Diabetes and its Complications Open access Feb 2020 16
15 Exploratory digital outcome measures of motor sign progression in Parkinson’s disease patients treated with prasinezumab Kirsten I. Taylor et al. · npj Digital Medicine Open access314 authors 16 Jun 2025 14
16 Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment Erik Mogalian, Diana M. Brainard, Anu O Osinusi et al. · Clinical Pharmacokinetics 8 Mar 2018 14
17 P1–343: A phase II study of the gamma‐secretase inhibitor avagacestat (BMS‐708163) in predementia Alzheimer's disease Vlad Coric, Stephen Salloway, Christopher van Dyck et al. · Alzheimer s & Dementia Jul 2013 11
18 Health care resource utilization and costs in patients with painful diabetic neuropathy treated with 10 kHz spinal cord stimulation therapy Rod Stephen Taylor, Shivanand Pramod Lad, Judith L. White et al. · Journal of Managed Care & Specialty Pharmacy Open access 23 Aug 2023 7
19 Preschool Behavioural and Emotional Outcomes Associated with Participation in Early Childhood Education and Care Stephanie D’Souza, Tom I. Stewart, Sarah L. Gerritsen et al. · Early Education and Development 26 Oct 2021 5
20 Results from a phase 1b multiple ascending-dose study of PRX002/RG7935, an Anti-alpha-synuclein monoclonal antibody, in patients with Parkinson’s disease Joseph J. Jankovic, Ira J. Goodman, Beth Safirstein et al. · Parkinsonism & Related Disorders 2018 4
21 Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials Gennaro Pagano et al. · npj Parkinson s Disease Open access312 authors Jul 2025 3
22 Pre‐pivotal clinical study of β‐amyloid in the ocular lens by Sapphire II‐aftobetin eye scan: Correlation with amyloid PET imaging in mild cognitive impairment (MCI) and mild Alzheimer’s disease (AD) Lee E. Goldstein, Susanne Wilke, Ira J. Goodman et al. · Alzheimer s & Dementia Dec 2021 3
23 O4‐02‐01: PHASE 2A RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED TRIAL OF THE HISTONE DEACETYLASE INHIBITOR (HDACI), FRM‐0334, IN ASYMPTOMATIC CARRIERS OF, OR PATIENTS WITH FRONTOTEMPORAL LOBAR DEGENERATION (FTLD) DUE TO, PROGRANULIN GENE MUTATIONS Adam L. Boxer et al. · Alzheimer s & Dementia Jul 2019 3
24 P1‐309: Correlation between baseline measures of amyloid‐positron emission tomography (PET) imaging, cerebral spinal fluid (CSF) biomarkers, and clinical scales in predementia Alzheimer's disease Vlad Coric, John Peter Seibyl, Mark A. Mintun et al. · Alzheimer s & Dementia Jul 2011 1
25 IC‐P‐108: VOLUMETRIC MRI RESULTS OF BMS AVAGACESTAT IN A PRODROMAL AD POPULATION Audrey Istace et al. · Alzheimer s & Dementia Jul 2014 0
26 P2‐414: Baseline clinical scores and volumetric MRI parameters across subjects randomized in mild‐to‐moderate (BMS CN156‐013) and predementia (BMS CN156‐018) Alzheimer's disease clinical trials of avagacestat Luc Bracoud, Vlad Coric, Christopher van Dyck et al. · Alzheimer s & Dementia Jul 2012 0
27 P4‐663: INITIATION OF THE PHASE 2/3 GAIN TRIAL OF COR388, A NOVEL BACTERIAL VIRULENCE FACTOR INHIBITOR FOR THE TREATMENT OF ALZHEIMER'S DISEASE (AD) BASED ON PHASE I A/B SAFETY, PK, BIOMARKER AND EFFICACY DATA Mike Detke, Casey C. Lynch, Leslie J. Holsinger et al. · Alzheimer s & Dementia Jul 2019 0
28 P2‐442: THE IMPACT OF A BRIEF, 2‐MINUTE DELAYED WORD RECALL TASK IN ASSESSING VERBAL MEMORY FOR SUBJECTS WITH MILD COGNITIVE IMPAIRMENT Pamela Voccia, Katherine Kruczek, Cristina Montes de Oca et al. · Alzheimer s & Dementia Jul 2019 0
29 P2‐245: A PRE‐PIVOTAL STUDY: B‐AMYLOID PLAQUE DETECTION IN THE LENS OF THE EYE IN MCI AND MILD AD ‐ CORRELATON WITH AMYLOID PET SCANNING Carl Sadowsky, Daniel R. Vlock, Tersea Villena et al. · Alzheimer s & Dementia Open access Jul 2019 0
30 [P4–403]: EVALUATION OF RAPID, ON‐SITE APOE GENETIC TESTING FOR SUBJECT OUTREACH AND RECRUITMENT Stephen Thein, Sharon L. Cohen, Ira J. Goodman et al. · Alzheimer s & Dementia Open access Jul 2017 0
31 [P4–487]: PATIENT ENGAGEMENT IN ALZHEIMER's AND MILD COGNITIVE IMPAIRMENT CLINICAL TRIALS Marieke I. Cajal, Craig T Curtis, Ira J. Goodman · Alzheimer s & Dementia Jul 2017 0
32 P3‐060: Alzheimer's Disease Registry: Providing Data to Describe the Clinical and Genetic Profiles of Individuals with Known Family History of Alzheimer’s Disease Jessica N. Branning, Sean P. Stanton, Caroline Smith et al. · Alzheimer s & Dementia Jul 2016 0
33 IC‐P‐140: Baseline clinical scores and volumetric MRI parameters across subjects randomized in mild‐to‐moderate (BMS CN156‐013) and predementia (BMS CN156‐018) Alzheimer's disease clinical trials of avagacestat Luc Bracoud, Vlad Coric, Christopher van Dyck et al. · Alzheimer s & Dementia Jul 2012 0
34 P2‐202: VOLUMETRIC MRI RESULTS OF BMS AVAGACESTAT IN A PRODROMAL AD POPULATION Audrey Istace et al. · Alzheimer s & Dementia Jul 2014 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.